BHPSA
BETTER HEALTH PROGRAMME SOUTH AFRICA
CASE STUDIES SEPTEMBER 2020
NCDs and COVID-19 in South Africa WHAT HAVE WE LEARN ED?
NCDs
Expert evidence
Since the start of the COVID-19 epidemic in China it was clear that people living with noncommunicable (NCDs) diseases were more vulnerable to severe COVID-19 illness and death. On September 15, leading South African experts discussed the links between the two diseases in a webinar hosted by the Better Health Programme (BHPSA) in conjunction with the World Health Organization (WHO) and the SA National Department of Health (NDoH). This webinar arose out of a substantial review of global evidence requested from BHPSA by the NDoH in April, in order to guide their COVID-19 public health strategy.
Prof Tarryn Young, from the University of Stellenbosch’s Centre for Evidence-based Health Care, presented the early global evidence from the BHPSAfunded study. A review of over 80 academic papers (May to mid-June 2020) concluded that the risk of hospitalisation, severe illness and death for COVID-19 was much higher in patients who had heart disease, diabetes and hypertension. Patients whose diabetes was well controlled were at less risk than those with uncontrolled disease.
The webinar was opened by Nick Latta, the UK Prosperity Counsellor in South Africa, and skilfully chaired by WHO’s NCD adviser in South Africa, Dr Kibachio Joseph Mwangi, both of whom framed the session with remarks on how coronavirus had exposed the extent of the NCD epidemic in the country. Prof Jean-Marie Dangou, WHO AFRO region’s NCD coordinator, noted that additionally, the COVID-19 epidemic had disrupted NCD services across the continent and had become an amplifier for health system weaknesses.
More recent evidence from South Africa was presented by Dr Mary Ann Davies a public health specialist and doctor in the Western Cape Department of Health (WCDoH)and Dr Waasila Jassat from the National Institute of Disease Control (NICD).
1
BHPSA BETTER HEALTH PROGRAMME SOUTH AFRICA